Avanyx amends IPO

Avanyx Therapeutics Inc. (Newton, Mass.) amended its IPO and now hopes to raise up to $15 million through the sale of 15 million shares at $1. The price would value the company at $25 million. In February, Avanyx filed to raise up to $30 million through the sale of 15 million shares at $2. The offering is not underwritten. Avanyx will seek listing on the OTC Bulletin Board. ...